Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Laboratory Medicine|August 21, 2018
Toll-Like Receptor 4 as an Immune Receptor Against Mycobacterium tuberculosis: A Systematic ReviewZahra Sepehri, Zohre Kiani, Farhad Kohan, et al.
Cellular & Molecular Biology Letters|May 25, 2017
Toll-like receptor 2 and type 2 diabetesZahra Sepehri, Zohre Kiani, Ali Akbar Nasiri, et al.
Iranian Red Crescent Medical Journal|November 13, 2014
The prevalence of zinc deficiency in patients with thalassemia in South East of iran, sistan and baluchistan provinceMohammad Ali Mashhadi, Zahra Sepehri, Zahra Heidari, et al.
Life Sciences|May 5, 2017
Toll like receptor 4 and hepatocellular carcinoma; A systematic reviewZahra Sepehri, Zohre Kiani, Farhad Kohan, et al.
Immunology Letters|October 29, 2017
Inflammasomes and type 2 diabetes: An updated systematic reviewZahra Sepehri, Zohre Kiani, Mahdi Afshari, et al.
Life Sciences|July 5, 2016
The link between TLR7 signaling and hepatitis B virus infectionZahra Sepehri, Zohre Kiani, Seyed Moayed Alavian, et al.
Bulletin of Emergency and Trauma|May 11, 2016
Economic Burden of Road Traffic Accidents; Report from a Single Center from South Eastern IranAliyeh Sargazi, Atefeh Sargazi, Prigil Kumar Nadakkavukaran Jim, et al.
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases|November 15, 2019
Essential and toxic metals in serum of individuals with active pulmonary tuberculosis in an endemic regionZahra Sepehri, Nima Mirzaei, Aliyeh Sargazi, et al.
Plos One|February 14, 2017
Correction: Atorvastatin, Losartan and Captopril Lead to Upregulation of TGF-β, and Downregulation of IL-6 in Coronary Artery Disease and HypertensionZahra Sepehri, Mohammad Masoumi, Nazanin Ebrahimi, et al.
Plos One|December 30, 2016
Atorvastatin, Losartan and Captopril Lead to Upregulation of TGF-β, and Downregulation of IL-6 in Coronary Artery Disease and HypertensionZahra Sepehri, Mohammad Masoumi, Nazanin Ebrahimi, et al.
Pageof 2